---
title: "Rite Aid 在破產後關閉了所有剩餘的門店"
description: "Rite Aid 在不到兩年的時間內因兩次破產申請關閉了所有門店，主要原因是債務累積、阿片類藥物危機訴訟以及來自 Walgreens 和 CVS 的競爭。曾經是美國最大的藥店連鎖企業，該公司曾試圖進行重組，但最終未能克服長期挑戰。客户可以通過公司網站訪問他們的藥房歷史，並尋找新的藥房來滿足處方需求。Rite Aid 的衰退反映了行業面臨的重大壓力和錯失的併購機會"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/259981545.md"
published_at: "2025-10-05T12:21:03.000Z"
---

# Rite Aid 在破產後關閉了所有剩餘的門店

> Rite Aid 在不到兩年的時間內因兩次破產申請關閉了所有門店，主要原因是債務累積、阿片類藥物危機訴訟以及來自 Walgreens 和 CVS 的競爭。曾經是美國最大的藥店連鎖企業，該公司曾試圖進行重組，但最終未能克服長期挑戰。客户可以通過公司網站訪問他們的藥房歷史，並尋找新的藥房來滿足處方需求。Rite Aid 的衰退反映了行業面臨的重大壓力和錯失的併購機會

close Pharmacy chain Rite Aid closed all of its locations after filing for bankruptcy twice in less than two years. The retailer posted a brief announcement on its website. "All Rite Aid stores have now closed," the site states. "We thank our loyal customers for their many years of support." The website offers former customers their pharmacy and immunization history, as well as assistance with finding pharmacies that their prescriptions were transferred to. RITE AID FILES FOR BANKRUPTCY FOR SECOND TIME IN LESS THAN 2 YEARS The drugstore chain operated in the U.S. for more than 60 years. The company had opportunities to merge with Walgreens in 2017 and Albertsons in 2018, but rejected both, according to Investopedia. Back in 1987, Rite Aid was the largest drug store chain in the U.S. with more than 2,000 stores, according to the financial media website. RITE AID FILES FOR BANKRUPTCY: WHAT'S NEXT FOR ITS STORES The pharmacy chain was driven to file for bankruptcy protection in 2023 due to mounting debt and sluggish sales from heightened competition coupled with hundreds of lawsuits connected to its role in the opioid crisis. Rite Aid quickly initiated a store optimization plan that involved immediately closing 154 of its 2,284 stores. Over the course of the restructuring, Rite Aid closed hundreds of additional stores, leaving it with a footprint of about 1,245 locations by the time of its second bankruptcy filing in May 2025. CLICK HERE TO READ MORE ON FOX BUSINESS Its first restructuring reduced the U.S. pharmacy chain's debt, although it still had $2.5 billion in liabilities when it emerged as a private company owned by its lenders in 2024. The company also failed to address its long-term business challenges of inflationary pressures and increased competition by pharmacy chains Walgreens, CVS, Walmart and Amazon. FOX Business' Daniella Genovese contributed to this report.

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 西维斯在所有药店接受 TrumpRx 折扣卡 | CVS Health Corporation 宣布所有 CVS 药房将接受 TrumpRx 折扣卡。符合条件的患者可以在药房出示这些卡片，以获得某些药物的折扣。此外，CVS 药房还与 NovoCare 合作，帮助患者通过 TrumpRx 生 | [Link](https://longbridge.com/zh-HK/news/275171372.md) |
| 阿里发布千问 3.5，性能媲美 Gemini 3， Token 价格仅为其 1/18 | 阿里巴巴于 2 月 16 日发布了新一代大模型千问 Qwen3.5-Plus，性能媲美 Gemini 3 Pro，成为全球最强开源模型。该模型参数为 3970 亿，推理效率显著提升，API 价格为每百万 Token 仅 0.8 元，为 Ge | [Link](https://longbridge.com/zh-HK/news/276045921.md) |
| ECS Botanics 与 Nimbus Health 建立德国分销合作伙伴关系 | ECS Botanics Holdings Ltd：与 Nimbus Health 建立德国分销合作伙伴关系，Ozsuns 产品将通过 Nimbus 广泛的药房网络在全国范围内分销 | [Link](https://longbridge.com/zh-HK/news/275535849.md) |
| 忘掉 AI 股票：这家制药巨头正在通过 AI 主导药物研发 | 而且还有多种方式可以将这项技术变现 | [Link](https://longbridge.com/zh-HK/news/276017486.md) |
| Apimeds Pharmaceuticals 和 Lōkahi Therapeutics 宣布 FDA C 类会议已安排用于 LT-100（Apitox）\| APUS 股票新闻 | Apimeds Pharmaceuticals 和 Lōkahi Therapeutics 宣布与 FDA 举行一次 C 类会议，讨论 LT-100（Apitox），这是一种用于治疗骨关节炎的非阿片类生物制剂。会议定于 2026 年 5 月 | [Link](https://longbridge.com/zh-HK/news/275664271.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。